Scientists discover enzym that activates epigenetically silenced genes

For several years now, cancer researchers have been studying a mechanism that contributes to the development of malignant tumors: The cell attaches small molecules containing a carbon atom, called methyl groups, to specific building blocks of DNA, thereby individually switching off the genes thus labeled.

This silencing also affects the function of many tumor suppressor genes, which, in their unmethylated state, put the brakes on uncontrolled cell growth. In contrast to ‘real’ mutations, where DNA building blocks are exchanged or lost, these epigenetic changes are reversible. Therefore, this mechanism is considered to be a promising approach in fighting cancer.

The cell uses this mechanism of putting genes to sleep and waking them up again when needed for many regulation processes. Scientists have already found out how the methyl groups are attached. The reverse process of demethylation, however, has been poorly understood so far. Researchers from the divisions of Professor Dr. Christof Niehrs and Professor Dr. Frank Lyko at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now been able to identify a protein called Gadd45a as a key player in demethylation. Gadd45a is a long known protein that is involved in many cellular processes.

The researchers showed in a series of experiments that an increase of Gadd45a levels in the cells wakes deactivated genes from their sleep. Control experiments showed that methyl groups are indeed no longer attached to genes thus reactivated. In contrast, if Gadd45a is deliberately switched off, hypermethylation of many DNA areas is the result. When removing the methyl groups, as the investigators have further demonstrated, Gadd45a interacts with enzymes that are involved in DNA repair. The data obtained by Niehrs and Lyko indicate that Gadd45a induces DNA-cutting enzymes of the DNA repair troops to remove the methylated areas, which are subsequently replaced again by unmethylated building blocks.

“The role of Gadd45a for cancer development is shown in mice lacking this protein,” Niehrs und Lyko explained. “These animals suffer particularly often from malignant tumors. Now we are able to make sense of this: The knockdown of Gadd45a in these animals causes excessive methylation of tumor suppressor genes so that many of the natural tumor ‘brakes’ fail to work. Therefore, Gadd45a may also become an interesting target for clinical oncology.“

The task of the Deutsches Krebsforschungszentrum in Heidelberg (German Cancer Research Center, DKFZ) is to systematically investigate the mechanisms of cancer development and to identify cancer risk factors. The results of this basic research are expected to lead to new approaches in the prevention, diagnosis and treatment of cancer. The Center is financed to 90 percent by the Federal Ministry of Education and Research and to 10 percent by the State of Baden-Wuerttemberg. It is a member of the Helmholtz Association of National Research Centers (Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V.).


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study reveals how genes can alter the cancer-fighting power of fruits and fiber